Senores Pharmaceuticals IPO: GMP, Listing Price, Probable Listing Date-Details Here

Senores Pharmaceutical IPO opened for subscription on 20th December 2024, and will remain open for subscription till December 24, 2024. Senores Pharmaceuticals focuses on manufacturing and developing affordable and complex generics certified by global food and drugs authorities.

Senores Pharmaceutical: Details

Senores Pharmaceuticals IPO is a book built issue of Rs 582.11 crores. The issue is a combination of fresh issue of 1.28 crore shares aggregating to Rs 500.00 crores and offer for sale of 0.21 crore shares aggregating to Rs 82.11 crores. 

The IPO bidding opened for subscription on December 20, 2024 and will close on December 24, 2024. The allotment for the Senores Pharmaceuticals IPO is expected to be finalized on Thursday, December 26, 2024. Senores Pharmaceuticals IPO will list on BSE , NSE with tentative listing date fixed as Monday, December 30, 2024.

The IPO price band is set at Rs 372 to Rs 391 per share. The minimum lot size for an application is 38. The minimum amount of investment required by retail investors is ₹14,858. The minimum lot size investment for sNII is 14 lots (532 shares), amounting to Rs 2,08,012, and for bNII, it is 68 lots (2,584 shares), amounting to ₹10,10,344.

Senores Pharmaceuticals IPO: Bird's Eye View

IPO Open Date    Friday, December 20, 2024
IPO Close Date    Tuesday, December 24, 2024
Basis of Allotment    Thursday, December 26, 2024
Initiation of Refunds    Friday, December 27, 2024
Credit of Shares to Demat    Friday, December 27, 2024
Listing Date    Monday, December 30, 2024
Cut-off time for UPI mandate confirmation  5 PM on December 24, 2024
 

Senores Pharmaceutical: Grey Market Premium (GMP)

Senores Pharmaceuticals IPO last GMP is Rs 220. With the price band of Rs., 391, Senores Pharmaceuticals IPO's estimated listing price is Rs 611 (cap price + today's GMP).The expected percentage gain/loss per share is 56.27 per cent.